But the important role of SOX2 in CSC functions has not only been reported in breast cancer; silencing SOX2 in glioblastoma tumour-initiating cells drastically decreases their proliferative and tumourigenic potential [16], and SOX2 controls tumour initiation in squamous cell carcinoma [17]. This evidence concerns the gene SOX2 and breast cancer.